4//SEC Filing
White Karen Ann 4
Accession 0001209191-23-043516
CIK 0001818331other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:12 PM ET
Size
9.4 KB
Accession
0001209191-23-043516
Insider Transaction Report
Form 4
White Karen Ann
Chief People Officer
Transactions
- Sale
Class A Common Stock
2023-07-26$7.41/sh−61$452→ 4,761 total - Exercise/Conversion
Restricted Stock Unit
2023-07-25−137→ 1,091 total→ Class A Common Stock (137 underlying) - Exercise/Conversion
Class A Common Stock
2023-07-25+137→ 4,822 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001874118
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:12 PM ET
- Size
- 9.4 KB